Related references
Note: Only part of the references are listed.Competitive Inhibition of the Luminal Efflux by Multidrug and Toxin Extrusions, but Not Basolateral Uptake by Organic Cation Transporter 2, Is the Likely Mechanism Underlying the Pharmacokinetic Drug-Drug Interactions Caused by Cimetidine in the Kidney
Sumito Ito et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics
Atsushi Yonezawa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Mammalian MATE (SLC47A) transport proteins: impact on efflux of endogenous substrates and xenobiotics
Katja Damme et al.
DRUG METABOLISM REVIEWS (2011)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Relationship between Drug/Metabolite Exposure and Impairment of Excretory Transport Function
Maciej J. Zamek-Gliszczynski et al.
DRUG METABOLISM AND DISPOSITION (2009)
Kinetic considerations for the quantitative assessment of efflux activity and inhibition: Implications for understanding and predicting the effects of efflux inhibition
J. Cory Kalvass et al.
PHARMACEUTICAL RESEARCH (2007)
Integration of hepatic drug transporters and phase II metabolizing enzymes: Mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites
MJ Zamek-Gliszczynski et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Share Paper
